An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study.

Trial Profile

An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Aug 2010

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 13 Aug 2010 Planned end date changed from 1 Jan 2011 to 1 May 2014 as reported by ClinicalTrials.gov.
    • 13 Aug 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 14 May 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top